Microbiology concept, hand of medical worker on agar plate culture bacteria, resistance of pathogens and bacterial identification in lab.; Shutterstock ID 2142832239; tactic_ID: COL021281; cost_center: 10033062; job: ; client: ; other:
Core clinical molecular diagnostics involves applying molecular biology techniques to study human diseases, including infections, inherited conditions, and cancer. This field focuses primarily on patient care through advanced diagnostic methods. It uses genomic and proteomic analysis techniques, such as nucleic acid isolation and quantification, PCR amplification, sequencing, and STR analysis. These methods help identify biological markers in patients, allowing for more accurate medical testing and diagnosis.
The aging population is driving the rise in chronic diseases, such as genetic disorders, cancer, and infections, which increases the need for biomarker analysis to provide effective treatment. Research and development in genomics, proteomics, and molecular biology are also helping to fuel the market’s growth. Additionally, the growing demand for point-of-care diagnostics and personalized medicine is contributing to the market’s expansion.
North America held a dominant presence in the core clinical molecular diagnostics market in 2023. The presence of key players, state-of-the-art research and development facilities, technological advancements, and favorable government policies drive the market. In November 2022, the FedDev Ontario Minister announced an investment of $2 million for SQI Diagnostics, a leading diagnostics company, to discover and develop rapid diagnostic testing for the North American clinical and patient market. It is estimated that more than 30 million people are reported to have rare diseases in the US. While in Canada, it is estimated that one out of every twelve people has a rare disease. In 2023, 613,331 people died due to cancer in Canada, necessitating early detection and screening of cancer.
Asia-Pacific is estimated to grow fastest in the core clinical molecular diagnostics market during the forecast period. The rising geriatric population, increasing prevalence of chronic disorders, and increasing investments & collaborations drive the market. The rising demand for point-of-care (POC) diagnostics and in vitro diagnostics (IVD) for detecting and screening chronic disorders boosts the market. Several government organizations in China, India, and Japan have initiated various programs to enhance their availability and accessibility across the region. The Chinese government is investing heavily in building up the country’s in vitro diagnostics (IVD) testing capacity and meeting the strong clinical demand of an aging population.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/core-clinical-molecular-diagnostics-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5323
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global thyroid cancer diagnostics market is experiencing steady growth as advancements in medical technologies continue to enhance early detection,… Read More
The global autoimmune disease diagnostics market is poised for significant growth in the coming decade. Market forecasts indicate a surge… Read More
The Europe dermal filler market is witnessing remarkable growth, fueled by rising beauty consciousness, advancements in non-invasive aesthetic procedures, and… Read More
The AI in cancer drugs market is on a remarkable growth path, poised to generate substantial revenue between 2025 and… Read More
The global biostimulants market is on a steady rise. Valued at USD 3.06 billion in 2024, it's expected to grow… Read More
The dental insurance market is booming. In 2024, it was valued at $232.07 billion, grew to $253.72 billion in 2025,… Read More